These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 34896920)

  • 1. Synthesis of new clioquinol derivatives as potent α-glucosidase inhibitors; molecular docking, kinetic and structure-activity relationship studies.
    Wali S; Atia-Tul-Wahab ; Ullah S; Khan MA; Hussain S; Shaikh M; Atta-Ur-Rahman ; Choudhary MI
    Bioorg Chem; 2022 Feb; 119():105506. PubMed ID: 34896920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation.
    Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS
    Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of new 2-phenyl-1H-benzo[d]imidazole core-based potent α-glucosidase inhibitors: Synthesis, kinetic study, molecular docking, and in vivo anti-hyperglycemic evaluation.
    Li Y; Zhang JH; Xie HX; Ge YX; Wang KM; Song ZL; Zhu KK; Zhang J; Jiang CS
    Bioorg Chem; 2021 Dec; 117():105423. PubMed ID: 34717239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
    Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
    Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies.
    Asgari MS; Mohammadi-Khanaposhtani M; Kiani M; Ranjbar PR; Zabihi E; Pourbagher R; Rahimi R; Faramarzi MA; Biglar M; Larijani B; Mahdavi M; Hamedifar H; Hajimiri MH
    Bioorg Chem; 2019 Nov; 92():103206. PubMed ID: 31445191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel acyl hydrazide derivatives of polyhydroquinoline as potent anti-diabetic and anti-glycating agents: Synthesis, in vitro α-amylase, α-glucosidase inhibition and anti-glycating activity with molecular docking insights.
    Ur Rahman S; Alam A; Parveen Z; Zainab ; Assad M; Adnan Ali Shah S; Rafiq H; Ayaz M; Latif A; Naveed Umar M; Ali M; Ahmad M
    Bioorg Chem; 2024 Sep; 150():107501. PubMed ID: 38865858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose.
    Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C
    Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, Computational Study, and In Vitro α-Glucosidase Inhibitory Action of Thiourea Derivatives Based on 3-Aminopyridin-2(1
    Shulgau Z; Palamarchuk I; Sergazy S; Urazbayeva A; Gulyayev A; Ramankulov Y; Kulakov I
    Molecules; 2024 Jul; 29(15):. PubMed ID: 39125032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unveiling anti-diabetic potential of new thiazole-sulfonamide derivatives: Design, synthesis, in vitro bio-evaluation targeting DPP-4, α-glucosidase, and α-amylase with in-silico ADMET and docking simulation.
    Khamees Thabet H; Ammar YA; Imran M; Hamdy Helal M; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Abusaif MS; Ragab A
    Bioorg Chem; 2024 Oct; 151():107671. PubMed ID: 39067419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyramine Derivatives as Potent Therapeutics for Type 2 Diabetes: Synthesis and
    Bashir MA; Javaid K; Shaikh M; Choudhary MI; Siddiqui H
    Med Chem; 2020; 16(8):1124-1135. PubMed ID: 32003674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing benzenesulfonamide-thiazolidinone hybrids as multitarget directed ligands for efficient control of type 2 diabetes mellitus through targeting the enzymes: α-glucosidase and carbonic anhydrase II.
    Gamal MA; Fahim SH; Giovannuzzi S; Fouad MA; Bonardi A; Gratteri P; Supuran CT; Hassan GS
    Eur J Med Chem; 2024 May; 271():116434. PubMed ID: 38653067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.
    Wang G; Peng Z; Wang J; Li X; Li J
    Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and docking of indole sulfonamide as a potent inhibitor of α-glucosidase enzyme in streptozotocin -induced diabetic albino wistar rats.
    Taha M; Imran S; Salahuddin M; Iqbal N; Rahim F; Uddin N; Shehzad A; Khalid Farooq R; Alomari M; Mohammed Khan K
    Bioorg Chem; 2021 May; 110():104808. PubMed ID: 33756236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of new anti-diabetic potential agents based on paracetamol incorporating sulfa-drugs: Design, synthesis, α-amylase, and α-glucosidase inhibitors with molecular docking simulation.
    Khamees Thabet H; Ragab A; Imran M; Helal MH; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Rakan Alshammari M; S Abusaif M; A Ammar Y
    Eur J Med Chem; 2024 Sep; 275():116589. PubMed ID: 38878516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and in vitro α-glucosidase inhibition of novel dihydropyrano[3,2-c]quinoline derivatives as potential anti-diabetic agents.
    Nikookar H; Mohammadi-Khanaposhtani M; Imanparast S; Faramarzi MA; Ranjbar PR; Mahdavi M; Larijani B
    Bioorg Chem; 2018 Apr; 77():280-286. PubMed ID: 29421703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring fluorine-substituted piperidines as potential therapeutics for diabetes mellitus and Alzheimer's diseases.
    Mughal EU; Hawsawi MB; Naeem N; Hassan A; Alluhaibi MS; Ali Shah SW; Nazir Y; Sadiq A; Alrafai HA; Ahmed SA
    Eur J Med Chem; 2024 Jul; 273():116523. PubMed ID: 38795518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, molecular modelling, ADME prediction and anti-hyperglycemic evaluation of new pyrazole-triazolopyrimidine hybrids as potent α-glucosidase inhibitors.
    Pogaku V; Gangarapu K; Basavoju S; Tatapudi KK; Katragadda SB
    Bioorg Chem; 2019 Dec; 93():103307. PubMed ID: 31585262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic investigation of anthocyanidin derivatives as α-glucosidase inhibitors.
    Kim JH; Kim HY; Jin CH
    Bioorg Chem; 2019 Jun; 87():803-809. PubMed ID: 30978605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
    Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I
    Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of aroyl/heteroaroyl iminothiazolines featuring 2,4,5-trichlorophenyl moiety as a new class of potent, selective, and in vitro efficacious glucosidase inhibitors.
    Kazmi M; Zaib S; Amjad ST; Khan I; Ibrar A; Saeed A; Iqbal J
    Bioorg Chem; 2017 Oct; 74():134-144. PubMed ID: 28780150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.